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Background: Current asthma prevalence among adults in the United States has reached historically high levels.
Although national-level estimates indicate that asthma prevalence among adults increased by 33% from 2000 to 2009,
state-specific temporal trends of current asthma prevalence and their contributing risk factors have not been explored.
Methods: We used 2000–2009 Behavioral Risk Factor Surveillance System data from all 50 states and the District of
Columbia (D.C.) to estimate state-specific current asthma prevalence by 2-year periods (2000–2001, 2002–2003,
2004–2005, 2006–2007, 2008–2009). We fitted a series of four logistic-regression models for each state to evaluate
whether there was a statistically significant linear change in the current asthma prevalence over time, accounting
for sociodemographic factors, smoking status, and weight status (using body mass index as the indicator).
Results: During 2000–2009, current asthma prevalence increased in all 50 states and D.C., with significant increases in
46/50 (92%) states and D.C. After accounting for weight status in the model series with sociodemographic factors, and
smoking status, 10 states (AR, AZ, IA, IL, KS, ME, MT, UT, WV, and WY) that had previously shown a significant increase
did not show a significant increase in current asthma prevalence.
Conclusions: There was a significant increasing trend in state-specific current asthma prevalence among adults from
2000 to 2009 in most states in the United States. Obesity prevalence appears to contribute to increased current asthma
prevalence in some states.
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Current asthma prevalence among adults in the United
States has reached historically high levels. In 2009, 8.4%
of U.S. adults (19.5 million persons) reported asthma
compared with 7.2% (14.7 million persons) in 2000 [1,2].
Although national-level estimates indicate that asthma
prevalence among adults relatively increased by 33% (4.8
million persons) from 2000 to 2009 (almost 500,000
adults per year) [1,2], state specific temporal tends in
asthma prevalence and their contributing risk factors
have not been explored.
To determine the prevalence of current asthma in the
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reproduction in any medium, provided the orand Prevention (CDC) uses national and state-based sur-
veillance systems. Since the late 1970s, the National
Health Interview Survey (NHIS), a national-based survey
of households from all 50 states and the District of
Columbia (D.C.), has provided a national estimate of
asthma prevalence by population-based characteristics
each year in the United States [3]. However, a systematic
state-based survey, the Behavioral Risk Factor Surveil-
lance System (BRFSS), provides state-level estimates of
asthma prevalence by population-based characteristics
each year.
Estimates of current asthma prevalence from both the
national- (NHIS) and the state-based (BRFSS) surveys
show that current asthma prevalence among adults is in-
creasing [1,2,4-6] and continuing to vary by certain
sociodemographic, behavioral, and geographic factors
[7-12]. More specifically, asthma prevalence can vary byLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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[13-25] and non-modifiable (e.g., age and race status)
risk factors [7-11,26-30]; however, the extent to which
these risk factors contribute to increasing prevalence at
the state level over time has not been analyzed or deter-
mined. Identifying state-specific changes in asthma
prevalence and determining how known risk factors for
asthma contribute to changes in prevalence over time
are important for public health planning and for gener-
ating hypotheses for asthma prevention and control.
Methods
Sample population
We used cross-sectional data from the 2000–2009
BRFSS to estimate state-specific prevalence in current
asthma and evaluate the influence of risk factors on
current asthma prevalence [31]. BRFSS is a state-based
random-digit dialing telephone survey that annually
collects information on health conditions and risk be-
haviors of adults 18 years and older noninstitutionalized
U.S. population in all 50 states, D.C., and U.S. territories.
It uses a disproportionate stratified sample (DSS) design
that commonly divides telephone numbers into two
strata for sampling and also disproportionately samples
smaller geographically defined populations of interest
within a state. Further details on BRFSS survey methods
and data are available at www.cdc.gov/brfss/index.htm.
Measures
The outcome measure is current asthma status (yes or
no). In the 2000 BRFSS, all respondents were asked,
“Did a doctor ever tell you that you had asthma?” From
2001 to 2009, the BRFSS question was changed and all
respondents were asked, “Have you ever been told by a
doctor, nurse, or other health professional that you had
asthma?” From 2000 to 2009, if the respondent con-
firmed that they had been told they had asthma, they
then were asked, “Do you still have asthma?” We defined
current asthma as an affirmative response to both ques-
tions. To reduce the annual variability in survey mea-
sures [32], we combined two consecutive survey years
and categorized “year of survey” into five 2-year periods:
2000–2001, 2002–2003, 2004–2005, 2006–2007, and
2008–2009.
To evaluate the effect of known risk factors on current
asthma prevalence, we included BRFSS self-reported
sociodemographic factors (age, sex, race/ethnicity, edu-
cation, and household income) and modifiable behaviors
(smoking status and weight status) associated with
current asthma prevalence and available from BRFSS
[31]. Age was categorized into six groups: 18–24, 25–34,
35–44, 45–54, 55–64, and ≥65 years. Race and ethnicity
were categorized as non-Hispanic white, non-Hispanic
black, Hispanic, and other. Education was categorized asless than high school, completion of high school, some
college (including associate’s degree), and a bachelor's
degree or higher. Household income was categorized as:
<$15,000, $15,000–$24,999, $25,000–$49,999, $50,000–
$74,999, ≥$75,000, or missing. Missing income values
were included as a separate category because 13% of re-
cords in the 2000–2009 BRFSS did not specify income
values. We categorized smoking status into three groups:
current smokers (respondents who had smoked at least
100 cigarettes in their entire life and currently smoke),
previous smokers (respondents who had smoked at least
100 cigarettes in their entire life but no longer smoke),
and nonsmokers (respondents who had never smoked or
had smoked fewer than 100 cigarettes in their life). To
classify a respondent’s weight status, we used body mass
index (BMI; calculated as respondent’s reported weight
in kilograms divided by respondent’s reported height in
meters squared). Using BMI, we categorized weight sta-
tus into five groups: underweight (BMI <18.5 kg/m2),
healthy weight (18.5 kg/m2 ≤ BMI < 25.0 kg/m2), over-
weight (25.0 kg/m2 ≤ BMI < 30.0 kg/m2), obese (30.0 kg/
m2 ≤ BMI < 40.0 kg/m2), and morbidly obese (BMI
≥40.0 kg/m2) [33].
Statistical analysis
All statistical data analyses were conducted using SAS-
Callable SUDAAN software (Version 10, Research Tri-
angle Institute, NC). The BRFSS complex survey design
structures were considered in all current asthma out-
come estimates by state, year of survey, sociodemo-
graphic factors (sex, age, race/ethnicity, household
income, and education), smoking status, and weight sta-
tus; BRFSS final post-stratified sampling weights were
used in all statistical data analyses. We reported
weighted percentages with 95% confidence intervals
(CIs) for all population or subpopulation groups for
current asthma prevalence estimates. For all analyses, we
considered a P value of <0.05 significant. We fitted a
series of four logistic regression models to examine tem-
poral changes in asthma prevalence from 2000 to 2009
for the United States, each state, and D.C. The first
model (model I) included only the continuous variable
of 2-year survey periods to evaluate the linear trend in
the prevalence of current asthma over the time period
from 2000–2001 to 2008–2009. The second model
(model II) adjusted for sociodemographic factors (age,
sex, race/ethnicity, education, and household income) to
evaluate whether an increasing linear trend in current
asthma prevalence still existed. The third model (model
III) introduced smoking status to evaluate its impact on
the linear trends in current asthma prevalence after
adjusting for individual sociodemographic factors. The
fourth model (model IV) introduced weight status and
evaluated its effect on the linear trends in current
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demographic factors and smoking status. We used the
model-based predicted marginal prevalence ratios (PRs)
and prevalence differences (PDs) and P values from their
related t-Test to assess the direction and significance of
linear trends in current asthma prevalence after control-
ling for the temporal changes in population sociodemo-
graphics, smoking, and weight status within a state. The
model-adjusted prevalence differences for survey periods
2000–2001 compared to 2008–2009 were used to evalu-
ate the increasing magnitude of asthma prevalence [34].
Results
From 2000 to 2009, BRFSS collected records on
3,203,280 respondents from the 50 states and D.C. Of
these respondents, 159,407 (5.0%) were excluded from
the analysis because values for asthma status or sociode-
mographic factors other than household income, smok-
ing status, or weight status were missing; 3,043,873
respondents were included in the analysis. The average
sample size per year from 2000 to 2009 was 304,387
(range: from 174,810 in 2000 to 411,406 in 2007) and
per state was 6,000 (range: from 4,621 in WY to 16,112
in WA). Survey response rates varied by year and state;
the median state survey response rate for this time
period was a little more than 50% (detailed at http://
www.cdc.gov/brfss/technical_infodata/quality.htm).
Current asthma prevalence
Table 1 provides a summary of current asthma preva-
lence and unadjusted and adjusted prevalence ratios by
2-year periods, sociodemographic factors, smoking sta-
tus, and weight status. Current asthma prevalence rela-
tively increased by 18.2% nationally from 7.2% during
2000–2001 to 8.5% during 2008–2009. Population sub-
groups with asthma prevalence greater than the 2008–
2009 national level of 8.5% include persons who are:
female (9.8%), aged 18–24 years (9.4%), black, non-
Hispanics (9.3%); persons with: less than high school
education (9.3%), household income < $15,000 (11.6%),
household income $15,000-$25,000 (9.1%); and persons
who: currently smoke (9.2%), are obese (10.2%), or are
morbidly obese (18.2%). Population subgroups with
prevalence ratio (PR) estimates >1.5 for current asthma
include persons: who are female (PR: 1.69, 95% CI: 1.66-
1.72, compared to males); have household incomes
< $15,000 (PR: 1.58, 95% CI: 1.53-1.64, compared to
≥ $75,000); are obese (PR: 1.63, 95% CI: 1.60-1.67,
compared to healthy weight); or are morbidly obese (PR:
2.60, 95% CI: 2.52-2.68, compared to healthy weight).
Trends in current asthma prevalence
All 50 states and D.C. showed an increase in current
asthma unadjusted prevalence from 2000–2001 to2008–2009; and over the 10-year period, current asthma
prevalence increased by >2.0 percentage points in 9
states (AK, DC, HI, LA, NH, NJ, OK, PA, and SD) and
by 1.5-2.0 percentage points in 12 states (DE, KY, MD,
MI, NM, NY, OH, OR, TN, VA, VT, and WI) (Figure 1
and Table 2).
In the unadjusted analysis comparing two time periods
of current asthma prevalence, 2000–2001 to 2008–2009,
80% (40/50) of states and D.C. showed significant in-
creases. Only ten states (AR, AZ, CO, IA, MN, MT, ND,
NV, UT, and WV) showed increases in current asthma
prevalence that were not statistically significant (Figure 2
and Table 3 [model I]). After controlling for survey year
and changes in population sociodemographics, 46 states,
including 6 of the 10 states (AR, AZ, IA, ND, UT, and
WV) that showed insignificant increases in the un-
adjusted model (Figure 2 and [model I]), and D.C.
showed a significant increase in current asthma preva-
lence in 2008–2009 compared to 2000–2001 (Figure 2
and Table 3 [model II]). When we added smoking status
to the model with survey year and sociodemographic
factors, MT shows a significant increase in current
asthma prevalence and all other states keep unchanged
in their linear trends of current asthma prevalence
(Figure 2 and Table 3 [model III]) was observed except
MT. However, when we added weight status to the
model with survey year, sociodemographic factors, and
smoking status, 10 states (AR, AZ, IA, IL, KS, ME,
MTUT, WV , and WY,) that had previously shown a sig-
nificant increasing trend showed no significant increas-
ing linear trend in current asthma prevalence from 2000
to 2009 (Figure 2 and Table 3 [model IV]).
Discussion
Our findings indicate that current asthma prevalence
among adults increased significantly from 2000–2001 to
2008–2009 for the majority of states (40/50) and for the
U.S. as a whole. Our findings also suggest that place of
residence, sociodemographic factors, and modifiable be-
haviors such as obesity might have contributed to those
increases.
We considered population-based sociodemographic
factors in the analysis because asthma prevalence is
known to vary by certain population subgroups in the
United States. Consistent with previous studies [8-12],
asthma prevalence was higher among women than men
and among non-Hispanic black than non-Hispanic white
persons. Asthma was more prevalent among persons
with less than a high school education than among
persons with a bachelor degree, and also more prevalent
among persons with an annual household income
< $15,000 than among persons with a household in-
come ≥ $75,000. Over the last century, the demographic
changes for the nation in general reveal a decrease in
Table 1 U.S. adult current asthma prevalence and prevalence ratios (PR) by 2000–2009 BRFSS sample characteristics
Characteristics Subpopulation Sample size Prevalence* Unadjusted Adjusted#
Groups n = 3,043,873 % (95% CI†) PR (95% CI†) PR (95% CI†)
2-Year 2000–2001 374,137 7.21 (7.07, 7.35) Reference
Period 2002–2003 486,368 7.60 (7.47, 7.74) 1.04 (1.04, 1.05) 1.04 (1.04, 1.05)
2004–2005 629,633 7.99 (7.86, 8.12) 1.09 (1.07, 1.10) 1.09 (1.07, 1.10)
2006–2007 748,536 8.23 (8.10, 8.37) 1.13 (1.11, 1.15) 1.13 (1.11, 1.15)
2008–2009 805,199 8.52 (8.40, 8.65) 1.18 (1.15, 1.20) 1.18 (1.15, 1.20)
Sex Male 1,176,599 5.90 (5.82, 5.99) Reference
Female 1,867,274 9.83 (9.75, 9.92) 1.67 (1.64, 1.69) 1.69 (1.66, 1.72)
Age, 18 – 24 159,715 9.36 (9.11, 9.62) Reference
in years 25 – 34 388,151 7.65 (7.51, 7.80) 0.82 (0.79, 0.84) 0.79 (0.76, 0.82)
35 – 44 537,390 7.44 (7.32, 7.56) 0.79 (0.77, 0.82) 0.74 (0.72, 0.76)
45 – 54 623,754 7.98 (7.85, 8.10) 0.85 (0.83, 0.88) 0.75 (0.73, 0.78)
55 – 64 560,588 8.43 (8.29, 8.57) 0.90 (0.87, 0.93) 0.75 (0.73, 0.77)
≥ 65 774,275 7.28 (7.17, 7.40) 0.78 (0.75, 0.80) 0.63 (0.61, 0.65)
Race and White (NH)** 2,451,608 8.09 (8.03, 8.16) Reference
Ethnicity Black (NH) 234,974 9.26 (9.04, 9.49) 1.15 (1.12, 1.17) 0.96 (0.94, 0.99)
Hispanic 188,189 5.86 (5.66, 6.06) 0.72 (0.70, 0.75) 0.64 (0.62, 0.67)
Others 169,102 8.37 (8.09, 8.66) 1.03 (1.00, 1.07) 1.05 (1.01, 1.08)
Education < High school 310,985 9.26 (9.06, 9.46) 1.32 (1.28, 1.35) 1.12 (1.09, 1.16)
High school 936,827 7.85 (7.74, 7.96) 1.12 (1.10, 1.14) 0.93 (0.91, 0.95)
Some college 815,293 8.48 (8.36, 8.60) 1.21 (1.18, 1.23) 1.02 (1.00, 1.04)
>Bachelor degree 980,768 7.03 (6.93, 7.12) Reference
Household < $15, 000 301,442 11.6 (11.4, 11.9) 1.74 (1.69, 1.79) 1.58 (1.53, 1.64)
Income $15 k## ~ <$25 k 474,354 9.06 (8.90, 9.23) 1.35 (1.32, 1.39) 1.27 (1.24, 1.31)
$25 k ~ <$50 k 811,140 7.54 (7.42, 7.65) 1.13 (1.10, 1.15) 1.07 (1.05, 1.10)
$50 k ~ <$75 k 449,348 7.05 (6.91, 7.20) 1.05 (1.03, 1.08) 1.01 (0.98, 1.04)
≥$75 k 611,531 6.69 (6.57, 6.81) Reference
Unknown 396,058 7.99 (7.81, 8.16) 1.19 (1.16, 1.23) 1.15 (1.11, 1.18)
Smoking Never 1,595,769 7.23 (7.15, 7.31) Reference
Status Former 853,780 8.41 (8.29, 8.52) 1.16 (1.14, 1.18) 1.24 (1.22, 1.26)
Current 594,324 9.21 (9.07, 9.35) 1.27 (1.25, 1.3) 1.26 (1.24, 1.29)
Weight Underweight 50,089 8.70 (8.22, 9.20) 1.29 (1.22, 1.37) 1.10 (1.04, 1.17)
Status Healthy weight 1,063,457 6.75 (6.66, 6.85) Reference
Overweight 1,064,475 6.91 (6.81, 7.00) 1.02 (1.00, 1.04) 1.18 (1.15, 1.20)
Obese 639,896 10.2 (10.0, 10.3) 1.51 (1.48, 1.54) 1.63 (1.60, 1.67)
Morbidly obese 96,785 18.2 (17.7, 18.7) 2.69 (2.62, 2.78) 2.60 (2.52, 2.68)
*Weighted prevalence for complex survey design; #Adjusted by logistic regression for all factors listed; †CI = Confidence Interval;
**NH = Non-Hispanic; ##k = thousand.
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populations [35]. These findings, coupled with the pat-
tern of sociodemographic factors among adults with
asthma, suggest that the increase in asthma prevalence
among adults might be due, in part, to changes in popu-
lation subgroups. The number of population subgroups
with higher proportions of persons with asthma (e.g.,women, non-Hispanic black persons) has been increas-
ing at a higher rate than has subgroups with relatively
lower proportions of persons with asthma (e.g., men,
non-Hispanic white persons). When these changes were
accounted for in the analysis, the number of states with
a significant linear increasing trends in current asthma
prevalence increased from 40 (80%) to 46 (92%) states,
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Figure 1 Current asthma unadjusted prevalence by state.
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WV) and D.C. that had insignificant increasing linear
trends when state-specific changes in sociodemographic
subgroups were not considered.
In this analysis, the number of states with significant
increases in current asthma prevalence did not change
when smoking status was added to the model with sur-
vey year and sociodemographic factors. It seems that the
positive public health effects of tobacco control have be-
come overshadowed by other factors contributing to the
increase in current asthma prevalence in the last decade.
However, when weight status was considered with sur-
vey year, sociodemographic factors, and smoking status,
10 states (AK, IL, KS, ME, WY, AR, AZ, IA, UT, and
WV) that had previously shown a significant increase incurrent asthma prevalence when considering those vari-
ables showed no significant increase in prevalence.
These findings suggest that the high prevalence of
asthma among obese (10.2%, 95% CI 10.0-10.3) and
morbidly obese (18.2%, 95% CI 17.7-18.7) persons,
coupled with the increasing prevalence of obese persons
in the United States [36], could contribute to observed
increases in adult asthma prevalence in some states. An
analysis comparing two cycles of data from the National
Health and Nutrition Examination Survey (NHANES
2001–2002 and 2003–2004) similarly showed that adult
asthma prevalence is increasing with greater prevalence
among obese and morbidly obese adults [7].
Modifiable factors such as obesity and smoking have
been associated with the development of asthma
Table 2 Average 2-year current asthma unadjusted prevalence among adults by state, BRFSS, 2000–2009
State 2-year period
2000–2001 2002–2003 2004–2005 2006–2007 2008–2009
% (se*) % (se*) % (se*) % (se*) % (se*)
US 7.21 (0.07) 7.60 (0.07) 7.99 (0.07) 8.23 (0.07) 8.52 (0.07)
AK 7.17 (0.58) 8.30 (0.60) 8.48 (0.58) 8.64 (0.57) 9.23 (0.67)
AL 6.23 (0.38) 7.33 (0.38) 7.91 (0.40) 8.74 (0.44) 7.71 (0.37)
AR 6.81 (0.39) 7.46 (0.35) 7.45 (0.33) 7.24 (0.31) 7.93 (0.43)
AZ 8.66 (0.71) 8.65 (0.54) 7.36 (0.47) 8.85 (0.53) 10.2 (0.67)
CA 7.23 (0.32) 7.44 (0.33) 7.46 (0.32) 7.64 (0.31) 8.20 (0.23)
CO 7.36 (0.45) 7.95 (0.35) 8.48 (0.33) 7.86 (0.27) 8.18 (0.26)
CT 7.91 (0.31) 8.44 (0.32) 8.97 (0.35) 9.27 (0.34) 9.14 (0.43)
DC 7.62 (0.52) 8.60 (0.56) 9.10 (0.50) 9.65 (0.45) 10.0 (0.51)
DE 7.37 (0.46) 7.49 (0.40) 9.11 (0.47) 8.71 (0.46) 9.19 (0.55)
FL 5.71 (0.27) 6.29 (0.32) 7.03 (0.29) 6.71 (0.23) 6.97 (0.33)
GA 6.76 (0.36) 7.23 (0.34) 7.35 (0.38) 7.84 (0.30) 7.82 (0.45)
HI 7.36 (0.38) 6.27 (0.31) 7.53 (0.45) 8.02 (0.35) 9.49 (0.38)
IA 6.58 (0.34) 6.36 (0.34) 6.95 (0.31) 6.74 (0.31) 7.20 (0.32)
ID 7.83 (0.32) 7.83 (0.33) 7.64 (0.32) 8.91 (0.39) 8.62 (0.39)
IL 7.89 (0.41) 7.29 (0.28) 7.74 (0.34) 8.32 (0.36) 8.47 (0.36)
IN 7.85 (0.37) 7.78 (0.28) 8.28 (0.29) 8.52 (0.33) 9.18 (0.38)
KS 7.98 (0.34) 7.60 (0.32) 7.18 (0.24) 8.34 (0.30) 8.64 (0.27)
KY 8.01 (0.31) 9.67 (0.38) 8.53 (0.37) 8.55 (0.37) 9.87 (0.39)
LA 5.07 (0.25) 6.10 (0.28) 6.08 (0.31) 6.12 (0.29) 7.22 (0.32)
MA 9.03 (0.28) 9.44 (0.31) 9.68 (0.32) 9.89 (0.27) 10.3 (0.29)
MD 7.27 (0.39) 8.13 (0.39) 8.13 (0.33) 8.66 (0.32) 9.25 (0.34)
ME 9.12 (0.49) 9.99 (0.50) 9.85 (0.44) 9.96 (0.38) 10.6 (0.35)
MI 8.19 (0.42) 9.04 (0.37) 8.67 (0.29) 9.50 (0.35) 9.98 (0.32)
MN 6.89 (0.35) 7.15 (0.34) 7.98 (0.41) 7.72 (0.38) 7.22 (0.37)
MO 7.78 (0.40) 8.27 (0.41) 9.05 (0.42) 8.62 (0.43) 9.01 (0.46)
MS 6.14 (0.41) 6.54 (0.32) 7.09 (0.32) 6.74 (0.29) 7.34 (0.28)
MT 8.07 (0.47) 8.41 (0.43) 8.30 (0.37) 8.72 (0.37) 8.89 (0.36)
NC 6.69 (0.37) 6.78 (0.32) 7.02 (0.20) 7.31 (0.23) 7.71 (0.26)
ND 7.20 (0.44) 7.18 (0.38) 7.54 (0.39) 7.33 (0.39) 8.42 (0.41)
NE 6.22 (0.37) 7.16 (0.32) 6.83 (0.28) 7.76 (0.38) 7.39 (0.33)
NH 8.42 (0.44) 8.59 (0.33) 10.3 (0.36) 10.0 (0.36) 10.4 (0.39)
NJ 6.19 (0.29) 7.44 (0.41) 8.09 (0.22) 8.14 (0.30) 8.23 (0.28)
NM 6.95 (0.35) 7.36 (0.32) 9.12 (0.34) 8.52 (0.35) 8.49 (0.35)
NV 8.31 (0.56) 7.16 (0.47) 7.08 (0.50) 7.39 (0.45) 8.71 (0.55)
NY 7.62 (0.37) 7.81 (0.31) 9.18 (0.32) 8.71 (0.33) 9.36 (0.35)
OH 7.96 (0.43) 7.20 (0.35) 8.17 (0.41) 9.37 (0.48) 9.83 (0.33)
OK 6.67 (0.31) 7.34 (0.26) 8.41 (0.28) 8.80 (0.30) 9.48 (0.33)
OR 8.21 (0.38) 8.94 (0.38) 9.96 (0.31) 9.85 (0.40) 9.90 (0.45)
PA 7.01 (0.34) 8.10 (0.32) 8.45 (0.30) 8.97 (0.35) 9.20 (0.32)
RI 9.01 (0.39) 9.18 (0.38) 10.2 (0.43) 10.2 (0.45) 10.4 (0.42)
SC 6.63 (0.36) 5.94 (0.31) 7.07 (0.26) 7.61 (0.28) 8.02 (0.34)
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Table 2 Average 2-year current asthma unadjusted prevalence among adults by state, BRFSS, 2000–2009 (Continued)
SD 5.43 (0.26) 6.63 (0.32) 7.04 (0.30) 7.39 (0.34) 7.47 (0.35)
TN 7.06 (0.38) 8.11 (0.42) 8.26 (0.40) 8.57 (0.43) 8.57 (0.43)
TX 6.29 (0.26) 7.00 (0.28) 7.02 (0.28) 7.70 (0.38) 6.95 (0.29)
UT 7.42 (0.44) 7.64 (0.42) 7.96 (0.35) 8.35 (0.38) 8.19 (0.35)
VA 6.83 (0.44) 7.40 (0.36) 7.94 (0.36) 8.21 (0.41) 8.51 (0.51)
VT 8.02 (0.35) 8.59 (0.37) 9.09 (0.32) 9.46 (0.34) 9.90 (0.34)
WA 7.93 (0.34) 8.98 (0.29) 9.18 (0.19) 9.12 (0.19) 9.10 (0.20)
WI 7.77 (0.41) 7.99 (0.36) 8.89 (0.37) 8.95 (0.43) 9.53 (0.48)
WV 8.89 (0.43) 8.61 (0.38) 9.66 (0.41) 8.79 (0.41) 9.24 (0.38)
WY 8.47 (0.43) 7.37 (0.35) 7.76 (0.33) 8.45 (0.34) 9.12 (0.34)
Median 7.37 (0.46) 7.60 (0.32) 8.13 (0.33) 8.55 (0.37) 8.89 (0.36)
*se = standard error.
Zhang et al. BMC Public Health 2013, 13:1156 Page 7 of 11
http://www.biomedcentral.com/1471-2458/13/1156[13-20,22-25], decline in lung function, severity of
asthma symptoms, and diminished response to steroid
medication [37-42]. Although the pathophysiologic
mechanisms remain unclear, genetic studies indicate that
the relationship between asthma and obesity might be
explained by independent and combined biologic path-
ways [42]. An international population-based cohort
study that collected DNA samples from 9,167 partici-
pants found an independent association between obesity
and asthma (OR 2.4, 95% CI 1.7-3.2) and a stronger,
combined effect (OR 6.1, 95% CI 2.5-14.4) among nona-
topic obese persons [42]. An increased risk of asthma
onset and exacerbation has been found also amongModel I
Model III
Figure 2 Current asthma prevalence ratios (PRs) for 2008–2009 vs 20current or former smokers, especially among women
and nonatopic adults [43]. In one study among nonato-
pic adults, 20% of adult-onset asthma was attributed to
current smoking, suggesting that a large proportion of
adult-onset asthma could be prevented by smoking ces-
sation [43]. A population-based, nested, case–control
study of adults (aged 21–51 years) in Sweden reported
an increased risk for adult-onset asthma associated with
noninfectious rhinitis that occurred before asthma onset
(OR 5.4, 95% CI 4.0-7.2), especially among smoking
nonatopic adults (OR 9.1, 95% CI 5.3-15.4), and among
persons who smoked before asthma onset (OR 1.5, 95%
CI 1.1-21) [44].Model II
Model IV
00–2001.
Table 3 Current asthma prevalence ratios (PR) for 2008–2009 vs 2000–2001 and significance by state
State Model I Model II Model III Model IV
AL 1.26(1.11,1.42)*** 1.37(1.20,1.55)*** 1.37(1.21,1.55)*** 1.31(1.15,1.49)***
AK 1.23(1.03,1.48)* 1.28(1.06,1.54)** 1.28(1.06,1.54)** 1.21(1.00,1.46)*
AZ 1.19(0.98,1.43) 1.23(1.02,1.48)* 1.23(1.02,1.48)* 1.20(0.99,1.45)
AR 1.12(0.98,1.27) 1.18(1.04,1.35)* 1.18(1.03,1.35)* 1.12(0.98,1.29)
CA 1.12(1.02,1.23)* 1.19(1.08,1.31)*** 1.20(1.09,1.32)*** 1.15(1.05,1.27)**
CO 1.08(0.97,1.20) 1.11(0.99,1.24) 1.11(1.00,1.24) 1.11(0.99,1.25)
CT 1.16(1.05,1.29)** 1.23(1.11,1.36)*** 1.23(1.11,1.36)*** 1.18(1.06,1.32)**
DE 1.26(1.09,1.46)** 1.35(1.16,1.56)*** 1.35(1.17,1.56)*** 1.25(1.07,1.45)**
DC 1.30(1.12,1.50)*** 1.38(1.20,1.60)*** 1.39(1.20,1.61)*** 1.32(1.14,1.53)***
FL 1.19(1.06,1.33)** 1.24(1.11,1.39)*** 1.25(1.11,1.39)*** 1.19(1.06,1.34)**
GA 1.16(1.02,1.32)* 1.24(1.08,1.42)** 1.24(1.09,1.42)** 1.17(1.02,1.35)*
HI 1.37(1.22,1.55)*** 1.43(1.27,1.61)*** 1.43(1.27,1.62)*** 1.34(1.18,1.51)***
ID 1.14(1.02,1.27)* 1.20(1.08,1.34)** 1.21(1.09,1.35)*** 1.18(1.05,1.32)**
IL 1.13(1.01,1.27)* 1.17(1.04,1.31)** 1.18(1.05,1.32)** 1.12(1.00,1.26)
IN 1.18(1.06,1.31)** 1.21(1.09,1.35)*** 1.22(1.09,1.36)*** 1.17(1.05,1.31)**
IA 1.10(0.98,1.24) 1.19(1.05,1.34)** 1.19(1.05,1.34)** 1.13(1.00,1.28)*
KS 1.11(1.01,1.22)* 1.14(1.04,1.26)** 1.15(1.04,1.26)** 1.10(1.00,1.22)
KY 1.12(1.02,1.24)* 1.24(1.12,1.37)*** 1.23(1.12,1.37)*** 1.22(1.10,1.35)***
LA 1.33(1.18,1.49)*** 1.49(1.32,1.67)*** 1.49(1.32,1.67)*** 1.44(1.27,1.63)***
ME 1.12(1.01,1.25)* 1.19(1.06,1.32)** 1.19(1.06,1.33)** 1.11(0.99,1.25)
MD 1.24(1.11,1.39)*** 1.29(1.16,1.45)*** 1.30(1.17,1.45)*** 1.24(1.11,1.39)***
MA 1.13(1.05,1.21)** 1.17(1.08,1.26)*** 1.18(1.09,1.27)*** 1.14(1.06,1.23)***
MI 1.19(1.08,1.32)*** 1.24(1.12,1.37)*** 1.25(1.12,1.38)*** 1.19(1.07,1.32)**
MN 1.07(0.94,1.20) 1.09(0.96,1.23) 1.09(0.96,1.23) 1.07(0.94,1.21)
MS 1.16(1.03,1.32)* 1.24(1.09,1.40)** 1.23(1.08,1.40)** 1.16(1.02,1.33)*
MO 1.14(1.01,1.29)* 1.22(1.07,1.38)** 1.22(1.07,1.38)** 1.16(1.02,1.32)*
MT 1.10(0.97,1.24) 1.12(0.99,1.27) 1.13(1.00,1.27) 1.09(0.96,1.23)
NE 1.18(1.04,1.33)** 1.26(1.11,1.42)*** 1.26(1.11,1.42)*** 1.24(1.09,1.40)**
NV 1.08(0.91,1.28) 1.16(0.98,1.37) 1.16(0.98,1.38) 1.11(0.94,1.32)
NH 1.25(1.13,1.39)*** 1.31(1.18,1.46)*** 1.32(1.18,1.46)*** 1.26(1.13,1.40)***
NJ 1.28(1.16,1.42)*** 1.31(1.19,1.45)*** 1.32(1.19,1.46)*** 1.27(1.14,1.41)***
NM 1.23(1.10,1.36)*** 1.26(1.13,1.40)*** 1.26(1.13,1.41)*** 1.22(1.09,1.36)***
NY 1.23(1.11,1.36)*** 1.27(1.15,1.41)*** 1.28(1.15,1.42)*** 1.24(1.12,1.38)***
NC 1.16(1.04,1.29)** 1.28(1.15,1.43)*** 1.29(1.15,1.43)*** 1.19(1.06,1.33)**
ND 1.15(1.00,1.32) 1.21(1.05,1.39)** 1.21(1.06,1.39)** 1.17(1.01,1.35)*
OH 1.32(1.18,1.48)*** 1.38(1.23,1.55)*** 1.38(1.23,1.55)*** 1.32(1.17,1.49)***
OK 1.42(1.29,1.56)*** 1.45(1.32,1.60)*** 1.43(1.30,1.58)*** 1.36(1.23,1.51)***
OR 1.20(1.07,1.33)** 1.26(1.13,1.41)*** 1.27(1.14,1.42)*** 1.23(1.10,1.37)***
PA 1.29(1.16,1.42)*** 1.34(1.21,1.48)*** 1.34(1.22,1.48)*** 1.30(1.18,1.44)***
RI 1.16(1.05,1.29)** 1.22(1.10,1.36)*** 1.24(1.11,1.37)*** 1.18(1.06,1.31)**
SC 1.29(1.14,1.46)*** 1.38(1.23,1.56)*** 1.39(1.23,1.56)*** 1.35(1.19,1.53)***
SD 1.32(1.18,1.49)*** 1.41(1.25,1.58)*** 1.41(1.25,1.58)*** 1.37(1.21,1.54)***
TN 1.18(1.04,1.34)** 1.20(1.06,1.36)** 1.19(1.05,1.36)** 1.16(1.01,1.32)*
TX 1.12(1.01,1.24)* 1.19(1.08,1.32)*** 1.20(1.08,1.32)*** 1.17(1.05,1.29)**
Zhang et al. BMC Public Health 2013, 13:1156 Page 8 of 11
http://www.biomedcentral.com/1471-2458/13/1156
Table 3 Current asthma prevalence ratios (PR) for 2008–2009 vs 2000–2001 and significance by state (Continued)
UT 1.12(0.99,1.26) 1.16(1.03,1.32)* 1.17(1.04,1.33)* 1.13(1.00,1.29)
VT 1.23(1.11,1.35)*** 1.33(1.20,1.46)*** 1.33(1.20,1.46)*** 1.30(1.18,1.44)***
VA 1.24(1.07,1.43)** 1.31(1.14,1.52)*** 1.32(1.14,1.53)*** 1.27(1.10,1.48)**
WA 1.11(1.03,1.20)** 1.19(1.10,1.29)*** 1.20(1.11,1.30)*** 1.15(1.06,1.24)***
WV 1.04(0.93,1.16) 1.16(1.04,1.30)** 1.16(1.04,1.30)** 1.09(0.98,1.23)
WI 1.23(1.08,1.40)** 1.28(1.13,1.45)*** 1.28(1.13,1.46)*** 1.22(1.07,1.39)**
WY 1.13(1.01,1.27)* 1.16(1.04,1.30)* 1.17(1.04,1.31)** 1.11(0.99,1.25)
US 1.18(1.15,1.20)*** 1.23(1.20,1.26)*** 1.23(1.21,1.26)*** 1.18(1.15,1.20)***
*p value less 0.05; **p value less 0.01; ***p value less 0.001.
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other factors that could not be accounted for, such as
changes in state public health policies, public and pro-
fessional awareness of asthma symptoms, air pollution
exposures, geographic locations (urban vs rural settings),
and occupational exposures, might also be contributing
to the observed increase in current asthma prevalence.
Although the degree to which public and professional
awareness has influenced asthma prevalence estimates
could not be determined, the significant independent in-
crease in current asthma prevalence by sociodemo-
graphic factors, smoking status, and weight status from
this analysis suggests that the contribution might be
relatively low, unless increased awareness and reporting
of asthma symptoms follow similar patterns of variation.
Substantial clinical and epidemiologic evidence suggest
that indoor and outdoor air pollutants can increase
asthma symptoms [45-53], and increasing evidence indi-
cates that certain air pollutants can lead to asthma onset
[54-59]. Although fewer studies on new onset asthma
have been conducted among adults than children, sev-
eral cohort studies have found that traffic-related local
pollutants can contribute to the onset and manifestation
of asthma in adults [55,58,59]. Also, a substantial propor-
tion of adult-onset asthma has been attributed to occupa-
tional exposures [60-65]. In a population-based, 10-year
prospective study of 6,837 adults (aged 20–44 years at
study onset) from 13 countries that participated in the
European Community Respiratory Health Surveys (ECRHS
and ECRHS II) [66], Kogevinas et al. found large geo-
graphic variations in population attributable risk (PAR) for
adult-onset asthma due to occupational exposures (PAR
range 10-25%); significant excess risk for nurses (relative
risk [RR] 2.2, 95% CI 1.3-4.0); and increased risk for partic-
ipants who experienced an acute symptomatic inhalation
event (e.g., fire, mixing cleaning products, or chemical
spills) (RR 3.3, 95% CI 1.0-11.1) [61]. Another population-
based cohort study of all employed adults aged 25–59
years in Finland from 1986 to 1998 found that a large
proportion (400–500 new cases/million persons/year) of
adult-onset asthma might have been attributable tooccupational factors and, therefore, might have been
prevented [64].
The results of this study are based on the analysis of a
large representative population-based sample that was
obtained by using standardized sampling methods and
survey questions for all 50 states and D.C. over a 10-year
period. However, three potential sampling frame errors
that might have occurred due to nonresponse, noncover-
age, and self-reported measures should be considered
when interpreting the results. The median response rate
for BRFSS each year was ~50%; however, asthma preva-
lence estimates in this study are similar to estimates in
other studies with higher response rates, such as NHIS
[67]. Noncoverage may occur because BRFSS does not
survey institutionalized adults, the military, or residents
without home telephones. We used BRFSS-weighted ad-
justments to minimize the effect of nonresponse and
noncoverage. And, self-reported survey measurements
may be less accurate than those based on physical mea-
surements; however, a 1993 review of asthma question-
naires reported a sensitivity of 68% and specificity of
94% when self-reported asthma was compared to a clin-
ical diagnosis of asthma [68].
Conclusion
From 2000 to 2009, current asthma prevalence among
adults increased for all 50 states and D.C., with sig-
nificant increases in 46/50 (92%) states and D.C.
After accounting for changes in population-based socio-
demographic factors and smoking prevalence, the in-
creasing prevalence of obese and morbidly obese
persons in some states is associated with increasing
prevalence of asthma, and if causal, could contribute to
the increase.
Next steps
Advances in asthma prevention and control are likely to
originate from an understanding of population and en-
vironmental characteristics associated with temporal and
geographic variations in asthma occurrence across states.
Therefore, asthma surveillance systems that track these
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http://www.biomedcentral.com/1471-2458/13/1156changes should be developed, maintained, and expanded
within states and territories to support local-level ana-
lyses of population-based characteristics and environ-
mental factors. State-by-state analysis is useful not only
for public health planning but also for generating and
testing hypotheses to explain the etiologic risk factors
for asthma. Further study to identify changes in preva-
lence and their contributing risk factors at the state,
county, and community level should be pursued to im-
prove our understanding of asthma etiology, to identify
high-risk groups, and to support state- and local-level
intervention strategies to prevent asthma occurrence
and control asthma symptoms.
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